VBI Vaccines Inc.
VBIVDrugs in Pipeline
5
Phase 3 Programs
3
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
Sci-B-Vac-Lot B
Hepatitis B
Sci-B-Vac®
Hepatitis B
Hepatitis B Vaccination
Hepatitis B Vaccines
VBI-1901
Glioblastoma Multiforme
BRII-835 (VIR-2218)
Hepatitis B, Chronic
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Sci-B-Vac-Lot B | Phase 3 | Hepatitis B | - | - |
Sci-B-Vac® | Phase 3 | Hepatitis B | - | - |
Hepatitis B Vaccination | Phase 3 | Hepatitis B Vaccines | - | - |
VBI-1901 | Phase 2 | Glioblastoma Multiforme | - | - |
BRII-835 (VIR-2218) | Phase 2 | Hepatitis B, Chronic | - | - |
Frequently asked questions
What is in VBI Vaccines Inc.'s drug pipeline?→
CatalystAlert tracks 5 drug candidates in VBI Vaccines Inc.'s (VBIV) pipeline across Phase 3, Phase 2. Its lead program is Sci-B-Vac-Lot B (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is VBI Vaccines Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for VBI Vaccines Inc. (VBIV) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track VBIV biotech catalysts?→
Add VBIV to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow VBI Vaccines Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.